P.4.d.001 - Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalized anxiety disorder
Stein, D.J., Khoo, J.P., Van Ameringen, D.M., Hoschl, C., Ahokas, A., Bauer, M., Bitter, I., Jarema, M., Mosolov, S., Vavrusova, L., Picarel-Blanchot, F., Matharan, S., Olivier, V.
Published in European neuropsychopharmacology (01.10.2017)
Published in European neuropsychopharmacology (01.10.2017)
Get full text
Journal Article
Efficacy and safety of agomelatine 25-50 mg/day versus escitalopram 10-20 mg/day in severe generalized anxiety disorder
Stein, D.J., Khoo, J.P., Van Ameringen, D.M., Hoschl, C., Ahokas, A., Bauer, M., Bitter, I., Jarema, M., Mosolov, S., Vavrusova, L., Picarel-Blanchot, F., Matharan, S., Olivier, V.
Published in European neuropsychopharmacology (01.10.2017)
Published in European neuropsychopharmacology (01.10.2017)
Get full text
Journal Article